Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 6/2007

01-06-2007 | Original Article

Maternal kidney stones during pregnancy and adverse birth outcomes, particularly congenital abnormalities in the offspring

Authors: F. Bánhidy, N. Ács, E. H. Puhó, A. E. Czeizel

Published in: Archives of Gynecology and Obstetrics | Issue 6/2007

Login to get access

Abstract

Objective

The possible adverse birth outcomes, particularly congenital abnormalities (CAs) in pregnant women with kidney stones (KS) previously have not been evaluated; therefore, we decided to study this possible association.

Methods

The population-based data set of the Hungarian Case–Control Surveillance of CAs, 1980–1996, was used for this analysis.

Results

Of 22,843 newborns or fetuses with CAs, 69 (0.30%) had mothers with KS during pregnancy. Of 38,151 matched control newborns without any abnormalities, 147 (0.39%) had KS during pregnancy. KS were associated with an adjusted prevalence odds ratio (POR) with 95% CI of 0.8, 0.6–1.0 for CAs. A higher prevalence of maternal KS during the first trimester of pregnancy was not found in any CA group. There was no higher rate of preterm birth and low birthweight in the newborns of pregnant women with KS.

Conclusions

There is no higher risk for adverse birth outcomes particularly CAs in the offspring of mothers with KS and related drug treatments during pregnancy.
Literature
3.
go back to reference Borghi L, Meschi T, Amato F, Brigant A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5 year randomized prospective study. J Urol 155:839–844PubMedCrossRef Borghi L, Meschi T, Amato F, Brigant A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5 year randomized prospective study. J Urol 155:839–844PubMedCrossRef
4.
go back to reference Stamatelon KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823CrossRef Stamatelon KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823CrossRef
5.
go back to reference Trinchieri A, Ostini F, Nespoli R, Rovera F, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27–30PubMedCrossRef Trinchieri A, Ostini F, Nespoli R, Rovera F, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27–30PubMedCrossRef
6.
go back to reference Curhan GC, Willett WC, Knight EL, Stampfer MJ (2004) Dietary factors and risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med 164:885–891PubMedCrossRef Curhan GC, Willett WC, Knight EL, Stampfer MJ (2004) Dietary factors and risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med 164:885–891PubMedCrossRef
7.
go back to reference Shepard TH, Lemire T (2004) Catalog of teratogenic agents, 11th edn. Johns Hopkins University Press, Baltimore Shepard TH, Lemire T (2004) Catalog of teratogenic agents, 11th edn. Johns Hopkins University Press, Baltimore
8.
go back to reference Czeizel AE, Rockenbauer M, Siffel CS, Varga E (2001) Description and mission evaluation of the Hungarian Case–Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 63:176–185PubMedCrossRef Czeizel AE, Rockenbauer M, Siffel CS, Varga E (2001) Description and mission evaluation of the Hungarian Case–Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 63:176–185PubMedCrossRef
9.
go back to reference Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55:299–305PubMedCrossRef Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55:299–305PubMedCrossRef
10.
go back to reference Czeizel AE, Intódy ZS, Modell B (1993) What proportion of congenital abnormalities can be prevented? Brit Med J 306:499–503PubMedCrossRef Czeizel AE, Intódy ZS, Modell B (1993) What proportion of congenital abnormalities can be prevented? Brit Med J 306:499–503PubMedCrossRef
11.
go back to reference Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 12:409–416PubMedCrossRef Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 12:409–416PubMedCrossRef
12.
go back to reference Soucie JM, Thun MJ, Coates RK, McClellan W, Austin H (1994) Demographic and geographic variability of kidney stones in the United States. Kidney Int 46:893–895PubMed Soucie JM, Thun MJ, Coates RK, McClellan W, Austin H (1994) Demographic and geographic variability of kidney stones in the United States. Kidney Int 46:893–895PubMed
13.
go back to reference Heller H, Sakhaee K, Moe OW, Pak CY (2002) Etiological role of estrogen status on renal formation. J Urol 168:1923–1927PubMedCrossRef Heller H, Sakhaee K, Moe OW, Pak CY (2002) Etiological role of estrogen status on renal formation. J Urol 168:1923–1927PubMedCrossRef
14.
go back to reference Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT, the EuroMAP Group (2001) Recall bias in a case–control study on the use of medicine during pregnancy. Epidemiology 12:461–466PubMedCrossRef Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT, the EuroMAP Group (2001) Recall bias in a case–control study on the use of medicine during pregnancy. Epidemiology 12:461–466PubMedCrossRef
15.
go back to reference Laerum E, Larsen S (1984) Thiazide prophylaxis of urolithiasis: a double blind study in general practice. Acta Med Scand 215:383–389PubMedCrossRef Laerum E, Larsen S (1984) Thiazide prophylaxis of urolithiasis: a double blind study in general practice. Acta Med Scand 215:383–389PubMedCrossRef
16.
go back to reference Ellinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073CrossRef Ellinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073CrossRef
17.
go back to reference Gettman MT, Segura JW (1995) Struvite stones: diagnosis and current treatment concepts. J Endocrinol 13:653–658 Gettman MT, Segura JW (1995) Struvite stones: diagnosis and current treatment concepts. J Endocrinol 13:653–658
Metadata
Title
Maternal kidney stones during pregnancy and adverse birth outcomes, particularly congenital abnormalities in the offspring
Authors
F. Bánhidy
N. Ács
E. H. Puhó
A. E. Czeizel
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 6/2007
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-006-0277-1

Other articles of this Issue 6/2007

Archives of Gynecology and Obstetrics 6/2007 Go to the issue